Albuminuria Is the Key Driver of Kidney Benefit with Aldosterone Receptor Antagonists in Type 2 Diabetes. Ferreira JP, Mendonca L, Marques P, Neves JS, et al. J Am Soc Nephrol 2025 Sep 2. doi: 10.1681/ASN.0000000877.

Read + Share

Amedeo Smart

Independent Medical Education

Ferreira JP, Mendonca L, Marques P, Neves JS, et al. Albuminuria Is the Key Driver of Kidney Benefit with Aldosterone Receptor Antagonists in Type 2 Diabetes. J Am Soc Nephrol 2025 Sep 2. doi: 10.1681/ASN.0000000877.
PMID: 40892478